Timber Pharmaceuticals, Inc.
TMBR
TMBR was delisted on the 28th of November, 2023.
10 hedge funds and large institutions have $7.53M invested in Timber Pharmaceuticals, Inc. in 2016 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, reducing their positions, and 2 closing their positions.
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
43% more funds holding
Funds holding: 7 → 10 (+3)
18% more capital invested
Capital invested by funds: $6.39M → $7.53M (+$1.15M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$1.18M |
| 2 |
Franklin Resources
San Mateo,
California
|
+$815K |
| 3 |
NC
Nexthera Capital
New York
|
+$521K |
| 4 |
RI
RTW Investments
New York
|
+$498K |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$226K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$48K |
| 2 |
Nomura Holdings
Tokyo,
Japan
|
-$16K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Franklin Resources
San Mateo,
California
| $5.06M | +$815K | +36 | +13% |
|
|
SM
2
Sabby Management
Miami Beach,
Florida
| $845K | +$1.18M | +52 | New |
|
|
RI
3
RTW Investments
New York
| $764K | +$498K | +22 | +88% |
|
|
NC
4
Nexthera Capital
New York
| $377K | +$521K | +23 | New |
|
5
Vanguard Group
Malvern,
Pennsylvania
| $168K | +$159K | +7 | +233% |
|
|
DCM
6
DAFNA Capital Management
Los Angeles,
California
| $160K | +$226K | +10 | New |
|
|
TCM
7
Tenor Capital Management
New York
| $69K | +$90.6K | +4 | New |
|
8
LPL Financial
San Diego,
California
| $60K | +$67.9K | +3 | +300% |
|
9
Citadel Advisors
Miami,
Florida
| $16K | – | – | – |
|
|
LTFS
10
Ladenburg Thalmann Financial Services
Miami,
Florida
| $12K | +$22.6K | +1 | New |
|
|
BFA
11
BlackRock Fund Advisors
San Francisco,
California
| $2K | – | – | – |
|
12
Bank of America
Charlotte,
North Carolina
| $1K | – | – | – |
|
|
13
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$48K | -2 | Closed |
|
|
14
Nomura Holdings
Tokyo,
Japan
| – | -$16K | -1 | Closed |
|
|
15
UBS Group
Zurich,
Switzerland
| – | -$2K | – | – |
|
TMBR Hedge Fund Activity: Q1 2016 in Review
10 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Timber Pharmaceuticals, Inc. (TMBR) for Q1 2016, worth a combined $7.53M — up 18% from $6.39M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new TMBR positions and 2 closed out — a net gain of 3 holders — while 4 added to existing stakes and 0 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $1.18M. The largest seller was Susquehanna International Group, exiting entirely with an estimated $48K sold.
- 10 institutional investors held Timber Pharmaceuticals, Inc. (TMBR) as of Q1 2016, up from 7 in Q4 2015.
- Funds reported $7.53M of Timber Pharmaceuticals, Inc. stock for Q1 2016, up 18% quarter-over-quarter.
- 5 funds opened new Timber Pharmaceuticals, Inc. positions in Q1 2016 and 2 closed out, a net change of +3 holders.
- The largest Timber Pharmaceuticals, Inc. buyer in Q1 2016 was Sabby Management, an estimated $1.18M added.
- The largest Timber Pharmaceuticals, Inc. seller in Q1 2016 was Susquehanna International Group, an estimated $48K sold.
Based on aggregated 13F filings for Q1 2016.